Procalcitonin is a marker of significant interest in the medical field, particularly when it comes to diagnosing and managing infections. Produced in response to a bacterial infection, procalcitonin levels in the blood can help doctors determine the severity of an infection or sepsis, a life-threatening response to infection. Unlike other markers that may rise in various conditions, procalcitonin is relatively specific to bacterial infections, making it a valuable tool for clinicians. When a patient presents symptoms of an infection, measuring procalcitonin levels can aid in deciding whether antibiotics are needed, as elevated levels are often indicative of a bacterial cause. On the other hand, low levels of procalcitonin might suggest a viral infection or another non-bacterial cause, potentially guiding a clinician away from unnecessary antibiotic use. This distinction is crucial in the fight against antibiotic resistance, a growing concern in healthcare. Labs, like Labcorp, offer procalcitonin testing, providing clinicians with a quantitative measure of procalcitonin in the blood. This information, in conjunction with other clinical findings, helps healthcare providers make more informed decisions about diagnosis, the necessity of antibiotics, and, if used, monitoring the effectiveness of treatment. The use of procalcitonin as a biomarker is a testament to how advanced laboratory testing contributes to personalized and precise patient care. This marker is useful: → to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock; → to determine the change in PCT level over time as an aid in assessing the cumulative 28-day risk of all-cause mortality for patients diagnosed with severe sepsis or septic shock in the ICU or when obtained in the emergency department or other medical wards prior to ICU admission; → to aid in decision making on antibiotic therapy, for inpatients or patients in the emergency department with suspected or confirmed lower respiratory tract infections (LRTI) — defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of chronic obstructive pulmonary disease (AECOPD); → to aid in decision making on antibiotic discontinuation for patients with suspected or confirmed sepsis.

The "Production Markers" on the Boston Heart Cholesterol Balance® test provide crucial insights into the body's cholesterol synthesis. This test measures key precursors such as lathosterol and desmosterol, which are indicative of the primary pathways through which cholesterol is produced. Approximately 80% of in vivo cholesterol production occurs via the major pathway involving lathosterol, while the remaining 20% utilizes the pathway associated with desmosterol. By evaluating these markers, the test offers a detailed view of cholesterol biosynthesis, allowing healthcare providers to understand better and manage patients' cholesterol levels. This information is pivotal in tailoring treatment strategies, particularly in predicting and optimizing responses to lipid-lowering therapies such as statins and ezetimibe.

What is Progesterone? Progesterone is a vital hormone that plays a central role in reproductive and hormonal health—especially in women. It is primarily produced by the ovaries after ovulation during the second half of the menstrual cycle, and it helps prepare the body for a potential pregnancy. In smaller amounts, it’s also produced by the adrenal glands in both men and women, and by the placenta during pregnancy. Progesterone works in balance with estrogen to regulate your menstrual cycle, support mood, maintain uterine lining stability, and prevent estrogen from becoming dominant. In pregnancy, it helps support the early development of the embryo and maintains the uterine environment needed to carry a baby to term. Why This Test Matters The NutriStat Hormone Health Panel is designed to assess the full spectrum of hormonal balance, and progesterone is a cornerstone of that assessment. Whether you are dealing with irregular cycles, fertility issues, perimenopausal symptoms, or chronic fatigue, measuring progesterone can reveal critical insights about your hormonal state. Interpreting Your Progesterone Results Low Progesterone Low levels of progesterone can lead to a wide range of symptoms and issues, including: Irregular or missed periods PMS, mood swings, or anxiety Trouble sleeping or staying asleep Infertility or difficulty maintaining pregnancy Spotting between periods Estrogen dominance symptoms (e.g., breast tenderness, weight gain around hips, fibroids) Low progesterone is especially common in women who are not ovulating regularly, which can happen during perimenopause, after discontinuing hormonal birth control, or due to chronic stress, under-eating, or certain medical conditions like PCOS. High Progesterone Elevated progesterone levels are less common but can occur in cases such as: Pregnancy (especially after the first trimester) Progesterone supplementation or hormone therapy Certain ovarian cysts or tumors Adrenal gland disorders (e.g., congenital adrenal hyperplasia) In non-pregnant individuals, high levels without a clear cause should be evaluated further, especially if accompanied by symptoms such as bloating, fatigue, or mood changes. When is Progesterone Measured? In menstruating women, progesterone is ideally measured in the luteal phase—about 5 to 7 days after ovulation—when levels should naturally rise. If you’re unsure about your cycle timing, the NutriStat panel or your provider may help determine the best testing window. What Should I Do if My Progesterone is Out of Range? Abnormal progesterone levels don’t always mean something is wrong, but they can indicate that your hormones are out of balance. If your levels are low, your healthcare provider may suggest: Cycle tracking and ovulation support Nutritional or lifestyle changes (like managing stress or supporting adrenal health) Bioidentical progesterone therapy or other hormone-balancing treatments If levels are high and you’re not pregnant or on hormone therapy, further testing may be needed to rule out underlying conditions. Takeaway Progesterone is essential for reproductive health, hormone balance, and emotional well-being. When levels are off, it can affect everything from your period and fertility to your energy and mood. The NutriStat Hormone Health Panel helps identify these imbalances, giving you and your provider the information needed to take action toward better hormonal health.

Progesterone’s primary function during the menstrual cycle is to induce a secretory endometrium ready for implantation of a fertilized egg. Levels therefore increase during the luteal phase of the cycle after ovulation. If no implantation occurs, progesterone returns to follicular phase levels. If a pregnancy results, progesterone continues to rise to very high levels and carries out a variety of functions necessary to sustain the pregnancy. In some patients with infertility, ovulation may occur but luteal phase levels of progesterone are inadequate. Luteal phase deficiency is a result of inadequate progesterone production by the corpus luteum. During menopause, ovarian progesterone production dwindles, resulting in postmenopausal levels similar to those seen in men. Progesterone has wide-ranging physiological effects, including neuroprotection, maintenance of skin elasticity, and development of bone tissue. Progesterone also counteracts the proliferative effects of estrogen on the endometrium. When samples are collected after transdermal application of progesterone, saliva progesterone levels are higher than serum, indicating distribution of progesterone to tissues.

Progesterone’s primary function during the menstrual cycle is to induce a secretory endometrium ready for implantation of a fertilized egg. Levels therefore increase during the luteal phase of the cycle after ovulation. If no implantation occurs, progesterone returns to follicular phase levels. If a pregnancy results, progesterone continues to rise to very high levels and carries out a variety of functions necessary to sustain the pregnancy. In some patients with infertility, ovulation may occur but luteal phase levels of progesterone are inadequate. Luteal phase deficiency is a result of inadequate progesterone production by the corpus luteum. During menopause, ovarian progesterone production dwindles, resulting in postmenopausal levels similar to those seen in men. Progesterone has wide-ranging physiological effects, including neuroprotection, maintenance of skin elasticity, and development of bone tissue. Progesterone also counteracts the proliferative effects of estrogen on the endometrium. When samples are collected after transdermal application of progesterone, saliva progesterone levels are higher than serum, indicating distribution of progesterone to tissues.

Adult Female Reference Ranges for Progesterone: Pre-Menopausal Mid Follicular: < or = 0.3 ng/mL Pre-Menopausal Surge: 0.1-1.5 ng/mL Pre-Menopausal Mid Luteal: 6.7-22.2 ng/mL Postmenopausal Phase: < or = 0.2 ng/mL